Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check6 days agoChange DetectedDifference0.1%
- Check13 days agoChange DetectedAdded related topic tags: 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; no study content or layout changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check28 days agoChange DetectedThe government funding status notice and the related topic links were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check35 days agoChange DetectedThe page now lists 'Multiple myeloma' and 'MedlinePlus Genetics' under related topics. These additions provide quick access to broader context for users researching this condition.SummaryDifference0.1%
- Check42 days agoChange DetectedRemoved the disease label 'Multiple myeloma' and related topics such as MedlinePlus Genetics. This reduces disease context and discoverability of the study for users searching by condition or genetics resources.SummaryDifference0.5%
Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.